As a pharmaceutical company, ensuring that your products are safe, effective, and compliant with regulatory requirements is essential. One way to achieve this is through auditing. Auditing is a process that assesses your company’s practices, processes, and procedures to identify areas of improvement and compliance risks.

This blog explores the importance of auditing for pharmaceutical companies and how JensonR+ can help you achieve your auditing goals. 

Pharmaceutical companies operate in a highly regulated industry, where compliance is critical to success. Failure to comply with regulatory requirements can result in severe consequences, including product recalls, fines, lack of supply, and damage to your company’s reputation. Auditing helps identify supplier compliance risks and areas of improvement, allowing you to take corrective and preventative action before issues escalate. 

In addition to compliance, effective auditing can also drive improvements for your company’s efficiency and profitability. By identifying areas of waste, inefficiency, and suboptimal performance, you can optimise your operations and reduce costs. Auditing can also help you identify opportunities for innovation and growth, allowing you to stay ahead of the competition. 

Pharmaceutical companies are subject to numerous regulations and guidelines to ensure product safety, efficacy, and quality. These regulations are enforced by regulatory bodies such as the FDA, EMA, and MHRA and failure to comply can result in serious consequences. 

Compliance is critical for a number of reasons, including: 

  • Protecting public health and patient safety 

  • Ensuring product quality and efficacy 

  • Maintaining regulatory approval and market access 

  • Maintaining product supply

  • Mitigating legal and financial risks 

  • Enhancing company reputation and stakeholder trust 

JensonR+ is a trusted provider of GxP auditing for pharmaceutical and medical device companies. Our team of highly experienced auditors, which includes EU QPs, RPs and RPi’s, have extensive knowledge of the regulatory landscape and industry best practices across all the major dosage forms and medical devices. Allowing us to provide tailored and comprehensive auditing services covering the global supply chain. As part of the regulanet® network we also partner with experts in over 90 countries.

We offer a range of auditing services, including GMP (all dosage forms and starting materials), GDP, computer systems, medical devices and more. Our audits are designed to identify compliance risks and areas of improvement, allowing you to take corrective action quickly and efficiently. We also recommend best practices and process improvements, allowing you to optimise operations and reduce costs. 

This service can be particularly valuable for companies facing short-term capacity and/or capacity challenges.

We work collaboratively with clients to ensure we deliver in line with requirements and to ensure a consistent approach with suppliers during the audit(s).

Our team are also very experienced in providing support during supplier selection and due diligence activities.

Please get in touch to find out more.

Latest Opportunities

Calling Supply Chain Innovators: Grants of £100,000 Available!

Funding call for supply chain innovators for grants of up to £100,000 As a Research…

Medical devices regulations: targeted consultation on the indefinite recognition of CE marked devices

Summary This consultation invites views on proposals for recognising CE marked medical devices in Great Britain.…

Mental Health First Aid training offer for the Medilink Midlands network

What Red Umbrella offer With tailored delivery and expert integration, every Red Umbrella engagement is…

Latest News

Anglia Ruskin University - Patron Spotlight

Medilink Midlands offers Patronage to leading organisations that champion the medtech and life sciences sector. …

HORIBA to Build a New Global Headquarters

Advancing global operations and realigning domestic sites to strengthen the organisation and lay the groundwork…

MHRA launches a consultation on indefinite recognition of CE-marked medical devices

The Medicines and Healthcare products Regulatory Agency (MHRA) has today launched a consultation on proposals for indefinite recognition…

Your innovation deserves recognition

The Medilink Midlands Awards are now open, celebrating outstanding innovation across the region’s medtech and life sciences sector.

With 10 categories to enter, now’s the time to showcase your achievements.
Extended Deadline Date: 16th January

Start your application today.

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​

Almost There! Just Tell Us a Bit About You​